Jabil (JBL) 10-Q 1 Jul 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	May 31, 2022	Jun. 21, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	May 31, 2022
Document Transition Report	false
Entity File Number	001-14063
Entity Registrant Name	JABIL INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	38-1886260
Entity Address, Address Line One	10800 Roosevelt Boulevard North
Entity Address, City or Town	St. Petersburg
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33716
City Area Code	727
Local Phone Number	577-9749
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	JBL
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		137,554,586
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000898293
Current Fiscal Year End Date	--08-31

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	May 31, 2022	Aug. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,070	$ 1,567
Accounts receivable, net of allowance for doubtful accounts	3,193	3,141
Contract assets	1,276	998
Inventories, net	5,981	4,414
Prepaid expenses and other current assets	952	757
Total current assets	12,472	10,877
#REF!	3,894	4,075
Operating lease right-of-use asset	481	390
Goodwill	711	715
#REF!	167	182
Deferred income taxes	174	176
Other assets	272	239
Total assets	18,171	16,654
Current liabilities:
Current installments of notes payable and long-term debt	1	0
Accounts payable	7,082	6,841
Accrued expenses	4,744	3,734
Current operating lease liabilities	115	108
Total current liabilities	11,942	10,683
Notes payable and long-term debt, less current installments	2,874	2,878
Other liabilities	289	334
Non-current operating lease liabilities	405	333
Income tax liabilities	190	178
Deferred income taxes	114	111
Total liabilities	15,814	14,517
Commitments and contingencies
Jabil Inc. stockholders’ equity:
Preferred stock, $0.001 par value, authorized 10,000,000 shares; no shares issued and no shares outstanding	0	0
#REF!	0	0
Additional paid-in capital	2,622	2,533
Retained earnings	3,333	2,688
Accumulated other comprehensive loss	(20)	(25)
#REF!	(3,579)	(3,060)
Total Jabil Inc. stockholders’ equity	2,356	2,136
Noncontrolling interests	1	1
Total equity	2,357	2,137
Total liabilities and equity	$ 18,171	$ 16,654

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	May 31, 2022	Aug. 31, 2021
Statement of Financial Position [Abstract]
Property, plant and equipment, accumulated depreciation	$ 5,482	$ 5,033
Intangible assets, accumulated amortization	$ 464	$ 442
Preferred stock, par value (in usd per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	270,407,585	267,418,092
Common stock, shares outstanding (in shares)	138,851,189	144,496,077
Treasury stock at cost, shares (in shares)	131,556,396	122,922,015

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Income Statement [Abstract]
Net revenue	$ 8,328	$ 7,215	$ 24,448	$ 21,876
Cost of revenue	7,709	6,647	22,545	20,104
Gross profit	619	568	1,903	1,772
Operating expenses:
Selling, general and administrative	282	305	870	914
Research and development	8	10	25	27
Amortization of intangibles	8	12	24	35
Restructuring, severance and related charges	0	1	0	6
Operating income	321	240	984	790
Loss on debt extinguishment	4	0	4	0
Gain on securities	0	(2)	0	(2)
Other expense (income)	1	(4)	(2)	(7)
Interest income	(1)	(1)	(2)	(5)
Interest expense	39	34	105	97
Income before income tax	278	213	879	707
Income tax expense	60	43	198	184
Net income	218	170	681	523
Net income attributable to noncontrolling interests, net of tax	0	1	0	2
Net income attributable to Jabil Inc.	$ 218	$ 169	$ 681	$ 521
Earnings per share attributable to the stockholders of Jabil Inc.:
Basic (in usd per share)	$ 1.55	$ 1.14	$ 4.77	$ 3.49
Diluted (in usd per share)	$ 1.52	$ 1.12	$ 4.67	$ 3.41
Weighted average shares outstanding:
Basic (in shares)	140.4	148.1	142.6	149.5
Diluted (in shares)	143.3	152	145.8	152.8

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 218	$ 170	$ 681	$ 523
Other comprehensive income:
Change in foreign currency translation	(9)	15	(20)	26
Change in derivative instruments:
Change in fair value of derivatives	6	8	31	64
Adjustment for net losses (gains) realized and included in net income	9	(4)	6	(41)
Total change in derivative instruments	15	4	37	23
Actuarial loss	(5)	0	(15)	0
Prior service credit	1	0	3	0
Total other comprehensive income	2	19	5	49
Comprehensive income	220	189	686	572
Comprehensive income attributable to noncontrolling interests	0	1	0	2
Comprehensive income attributable to Jabil Inc.	$ 220	$ 188	$ 686	$ 570

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common stock:	Additional paid-in capital:	Retained earnings:	Accumulated other comprehensive (loss) income:	Treasury stock:	Noncontrolling interests:
Beginning Balance at Aug. 31, 2020	$ 1,825		$ 2,414	$ 2,041	$ (34)	$ (2,610)	$ 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock purchase plan			20
Purchase of noncontrolling interest			(14)				(13)
Recognition of stock-based compensation			71
Declared dividends				(37)
Net income attributable to Jabil Inc.	523			521			2
Other comprehensive income	49				49
Purchases of treasury stock under employee stock plans						(21)
Treasury shares purchased						(262)
Declared dividends to noncontrolling interests							(2)
Ending Balance at May. 31, 2021	2,139	$ 0	2,491	2,525	15	(2,893)	1
Beginning Balance at Feb. 28, 2021	2,102		2,488	2,368	(4)	(2,763)	13
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock purchase plan			0
Purchase of noncontrolling interest			(14)				(13)
Recognition of stock-based compensation			17
Declared dividends				(12)
Net income attributable to Jabil Inc.	170			169			1
Other comprehensive income	19				19
Purchases of treasury stock under employee stock plans						0
Treasury shares purchased						(130)
Declared dividends to noncontrolling interests							0
Ending Balance at May. 31, 2021	2,139	0	2,491	2,525	15	(2,893)	1
Beginning Balance at Aug. 31, 2021	2,137		2,533	2,688	(25)	(3,060)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock purchase plan			26
Purchase of noncontrolling interest			0				0
Recognition of stock-based compensation			63
Declared dividends				(36)
Net income attributable to Jabil Inc.	681			681			0
Other comprehensive income	5				5
Purchases of treasury stock under employee stock plans						(44)
Treasury shares purchased						(475)
Declared dividends to noncontrolling interests							0
Ending Balance at May. 31, 2022	2,357	0	2,622	3,333	(20)	(3,579)	1
Beginning Balance at Feb. 28, 2022	2,338		2,608	3,127	(22)	(3,376)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock purchase plan			0
Purchase of noncontrolling interest			0				0
Recognition of stock-based compensation			14
Declared dividends				(12)
Net income attributable to Jabil Inc.	218			218			0
Other comprehensive income	2				2
Purchases of treasury stock under employee stock plans						0
Treasury shares purchased						(203)
Declared dividends to noncontrolling interests							0
Ending Balance at May. 31, 2022	$ 2,357	$ 0	$ 2,622	$ 3,333	$ (20)	$ (3,579)	$ 1

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	May 31, 2022	May 31, 2021
Cash flows provided by operating activities:
Net income	$ 681	$ 523
Depreciation, amortization, and other, net	768	730
Change in operating assets and liabilities, exclusive of net assets acquired	(704)	(582)
Net cash provided by operating activities	745	671
Cash flows used in investing activities:
Acquisition of property, plant and equipment	(1,068)	(878)
Proceeds and advances from sale of property, plant and equipment	470	287
Cash paid for business and intangible asset acquisitions, net of cash	(18)	(50)
Other, net	0	(3)
Net cash used in investing activities	(616)	(644)
Cash flows used in financing activities:
Borrowings under debt agreements	2,621	1,081
Payments toward debt agreements	(2,707)	(908)
Payments to acquire treasury stock	(475)	(262)
Dividends paid to stockholders	(37)	(38)
Net proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan	26	20
Treasury stock minimum tax withholding related to vesting of restricted stock	(44)	(21)
Other, net	(23)	(49)
Net cash used in financing activities	(639)	(177)
Effect of exchange rate changes on cash and cash equivalents	13	(3)
Net decrease in cash and cash equivalents	(497)	(153)
Cash and cash equivalents at beginning of period	1,567	1,394
Cash and cash equivalents at end of period	$ 1,070	$ 1,241

Basis of Presentation

Basis of Presentation	9 Months Ended
	May 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of PresentationThe accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary to present fairly the information set forth therein have been included. Jabil Inc. (the “Company”) has made certain reclassification adjustments to conform prior periods’ Condensed Consolidated Financial Statements to the current presentation. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in the Annual Report on Form 10-K of Jabil Inc. (the “Company”) for the fiscal year ended August 31, 2021. Results for the nine months ended May 31, 2022 are not necessarily an indication of the results that may be expected for the full fiscal year ending August 31, 2022.

Trade Accounts Receivable Sale

Trade Accounts Receivable Sale Programs	9 Months Ended
	May 31, 2022
Transfers and Servicing [Abstract]
Trade Accounts Receivable Sale Programs	Trade Accounts Receivable Sale Programs The Company regularly sells designated pools of high credit quality trade accounts receivable, at a discount, under uncommitted trade accounts receivable sale programs to unaffiliated financial institutions without recourse. As these accounts receivable are sold without recourse, the Company does not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions. As of May 31, 2022, the Company may elect to sell receivables and the unaffiliated financial institution may elect to purchase specific accounts receivable at any one time up to a: (i) maximum aggregate amount available of $2.0 billion under nine trade accounts receivable sale programs, (ii) maximum amount available of 400 million CNY under one trade accounts receivable sale program and (iii) maximum amount available of 100 million CHF under one trade accounts receivable sale program. The trade accounts receivable sale programs expire on various dates through 2025. The Company continues servicing the receivables sold and in exchange receives a servicing fee under each of the trade accounts receivable sale programs. Servicing fees related to the trade accounts receivable sale programs recognized during the three months and nine months ended May 31, 2022 and 2021 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities. In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Trade accounts receivable sold (1) $ 2,575 $ 1,016 $ 6,509 $ 3,567 Cash proceeds received $ 2,572 $ 1,015 $ 6,504 $ 3,565 Pre-tax losses on sale of receivables (2) $ 3 $ 1 $ 5 $ 2 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) Recorded to other expense within the Condensed Consolidated Statement of Operations. Certain Jabil entities participating in the global asset-backed securitization program continuously sell designated pools of trade accounts receivable to a special purpose entity, which in turn sells certain of the receivables at a discount to conduits administered by an unaffiliated financial institution on a monthly basis. In addition, a foreign entity participating in the global asset-backed securitization program sells certain receivables at a discount to conduits administered by an unaffiliated financial institution on a daily basis. The Company terminated the foreign asset-backed securitization program on June 28, 2021. The Company continues servicing the receivables sold and in exchange receives a servicing fee under the global asset-backed securitization program. Servicing fees related to the asset-backed securitization programs recognized during the three months and nine months ended May 31, 2022 and 2021 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities. The special purpose entity in the global asset-backed securitization program is a wholly-owned subsidiary of the Company and is included in the Company’s Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of May 31, 2022. The global asset-backed securitization program expires on November 25, 2024 and the maximum amount of net cash proceeds available at any one time is $600 million. As of May 31, 2022, the Company had no available liquidity under its global asset-backed securitization program. In connection with the asset-backed securitization programs, the Company recognized the following (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 (4) May 31, 2022 May 31, 2021 (4) Trade accounts receivable sold (1) $ 947 $ 1,074 $ 2,979 $ 3,388 Cash proceeds received (2) $ 942 $ 1,072 $ 2,971 $ 3,381 Pre-tax losses on sale of receivables (3) $ 5 $ 2 $ 8 $ 7 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) The amounts primarily represent proceeds from collections reinvested in revolving-period transfers. (3) Recorded to other expense within the Condensed Consolidated Statements of Operations. (4) Activity includes the foreign asset-backed securitization program which terminated on June 28, 2021.

Inventories

Inventories	9 Months Ended
	May 31, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories consist of the following (in millions): May 31, 2022 August 31, 2021 Raw materials $ 4,722 $ 3,142 Work in process 699 677 Finished goods 646 680 Reserve for excess and obsolete inventory (86) (85) Inventories, net $ 5,981 $ 4,414

Leases

Leases	9 Months Ended
	May 31, 2022
Leases [Abstract]
Leases	Leases During fiscal year 2022, the Company entered into new operating and finance leases. The future minimum lease payments under these new leases as of May 31, 2022 were as follows (in millions): Payments due by period Total Less than 1 1-3 years 3-5 years After 5 years Operating lease obligations (1) $ 180 $ 31 $ 56 $ 44 $ 49 Finance lease obligations (1) $ 74 $ 37 $ 36 $ 1 $ — (1) Excludes $33 million of payments related to leases signed but not yet commenced. Additionally, certain leases signed but not yet commenced contain residual value guarantees and purchase options not deemed probable.
Leases	Leases During fiscal year 2022, the Company entered into new operating and finance leases. The future minimum lease payments under these new leases as of May 31, 2022 were as follows (in millions): Payments due by period Total Less than 1 1-3 years 3-5 years After 5 years Operating lease obligations (1) $ 180 $ 31 $ 56 $ 44 $ 49 Finance lease obligations (1) $ 74 $ 37 $ 36 $ 1 $ — (1) Excludes $33 million of payments related to leases signed but not yet commenced. Additionally, certain leases signed but not yet commenced contain residual value guarantees and purchase options not deemed probable.

Notes Payable and Long-Term Deb

Notes Payable and Long-Term Debt	9 Months Ended
	May 31, 2022
Debt Disclosure [Abstract]
Notes Payable and Long-Term Debt	Notes Payable and Long-Term Debt Notes payable and long-term debt outstanding as of May 31, 2022 and August 31, 2021 are summarized below (in millions): Maturity Date May 31, 2022 August 31, 2021 4.700% Senior Notes (1) Sep 15, 2022 $ — $ 499 4.900% Senior Notes Jul 14, 2023 300 300 3.950% Senior Notes Jan 12, 2028 497 496 3.600% Senior Notes Jan 15, 2030 496 495 3.000% Senior Notes Jan 15, 2031 592 591 1.700% Senior Notes Apr 15, 2026 496 496 4.250% Senior Notes (1) May 15, 2027 493 — Borrowings under credit facilities (2) Jan 22, 2024 and Jan 22, 2026 — — Borrowings under loans Jul 31, 2026 1 1 Total notes payable and long-term debt 2,875 2,878 Less current installments of notes payable and long-term debt 1 — Notes payable and long-term debt, less current installments $ 2,874 $ 2,878 (1) On May 4, 2022, the Company issued $500 million of registered 4.250% Senior Notes due 2027 (the “Green Bonds” or the “4.250% Senior Notes”). On May 31, 2022, the net proceeds from the offering were used to redeem the Company’s 4.700% Senior Notes due in 2022 and pay the applicable “make-whole” premium and accrued interest. In addition, the Company intends to allocate an amount equal to the net proceeds from this offering to finance or refinance eligible expenditures under the Company’s new green financing framework. (2) As of May 31, 2022, the Company has $3.8 billion in available unused borrowing capacity under its revolving credit facilities. The senior unsecured credit agreement dated as of January 22, 2020 and amended on April 28, 2021 (the “Credit Facility”) acts as the back-up facility for commercial paper outstanding, if any. The Company has a borrowing capacity of up to $3.2 billion under its commercial paper program, which was increased from $1.8 billion on February 18, 2022. Debt Covenants Borrowings under the Company’s debt agreements are subject to various covenants that limit the Company’s ability to: incur additional indebtedness, sell assets, effect mergers and certain transactions, and effect certain transactions with subsidiaries and affiliates. In addition, the revolving credit facilities and the 4.900% Senior Notes contain debt leverage and interest coverage covenants. The Company is also subject to certain covenants requiring the Company to offer to repurchase the 4.900%, 3.950%, 3.600%, 3.000%, 1.700% or 4.250% Senior Notes upon a change of control. As of May 31, 2022 and August 31, 2021, the Company was in compliance with its debt covenants. Fair Value

Asset-Backed Securitization Pro

Asset-Backed Securitization Program	9 Months Ended
	May 31, 2022
Transfers and Servicing [Abstract]
Asset-Backed Securitization Program	Trade Accounts Receivable Sale Programs The Company regularly sells designated pools of high credit quality trade accounts receivable, at a discount, under uncommitted trade accounts receivable sale programs to unaffiliated financial institutions without recourse. As these accounts receivable are sold without recourse, the Company does not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions. As of May 31, 2022, the Company may elect to sell receivables and the unaffiliated financial institution may elect to purchase specific accounts receivable at any one time up to a: (i) maximum aggregate amount available of $2.0 billion under nine trade accounts receivable sale programs, (ii) maximum amount available of 400 million CNY under one trade accounts receivable sale program and (iii) maximum amount available of 100 million CHF under one trade accounts receivable sale program. The trade accounts receivable sale programs expire on various dates through 2025. The Company continues servicing the receivables sold and in exchange receives a servicing fee under each of the trade accounts receivable sale programs. Servicing fees related to the trade accounts receivable sale programs recognized during the three months and nine months ended May 31, 2022 and 2021 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities. In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Trade accounts receivable sold (1) $ 2,575 $ 1,016 $ 6,509 $ 3,567 Cash proceeds received $ 2,572 $ 1,015 $ 6,504 $ 3,565 Pre-tax losses on sale of receivables (2) $ 3 $ 1 $ 5 $ 2 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) Recorded to other expense within the Condensed Consolidated Statement of Operations. Certain Jabil entities participating in the global asset-backed securitization program continuously sell designated pools of trade accounts receivable to a special purpose entity, which in turn sells certain of the receivables at a discount to conduits administered by an unaffiliated financial institution on a monthly basis. In addition, a foreign entity participating in the global asset-backed securitization program sells certain receivables at a discount to conduits administered by an unaffiliated financial institution on a daily basis. The Company terminated the foreign asset-backed securitization program on June 28, 2021. The Company continues servicing the receivables sold and in exchange receives a servicing fee under the global asset-backed securitization program. Servicing fees related to the asset-backed securitization programs recognized during the three months and nine months ended May 31, 2022 and 2021 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities. The special purpose entity in the global asset-backed securitization program is a wholly-owned subsidiary of the Company and is included in the Company’s Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of May 31, 2022. The global asset-backed securitization program expires on November 25, 2024 and the maximum amount of net cash proceeds available at any one time is $600 million. As of May 31, 2022, the Company had no available liquidity under its global asset-backed securitization program. In connection with the asset-backed securitization programs, the Company recognized the following (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 (4) May 31, 2022 May 31, 2021 (4) Trade accounts receivable sold (1) $ 947 $ 1,074 $ 2,979 $ 3,388 Cash proceeds received (2) $ 942 $ 1,072 $ 2,971 $ 3,381 Pre-tax losses on sale of receivables (3) $ 5 $ 2 $ 8 $ 7 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) The amounts primarily represent proceeds from collections reinvested in revolving-period transfers. (3) Recorded to other expense within the Condensed Consolidated Statements of Operations. (4) Activity includes the foreign asset-backed securitization program which terminated on June 28, 2021.

Accrued Expenses

Accrued Expenses	9 Months Ended
	May 31, 2022
Accrued Liabilities, Current [Abstract]
Accrued Expenses	Accrued Expenses Accrued expenses consist of the following (in millions): May 31, 2022 August 31, 2021 Inventory deposits $ 1,254 $ 711 Contract liabilities (1) 733 559 Accrued compensation and employee benefits 729 827 Other accrued expenses 2,028 1,637 Accrued expenses $ 4,744 $ 3,734 (1) Revenue recognized during the nine months ended May 31, 2022 and 2021 that was included in the contract liability balance as of August 31, 2021 and 2020 was $269 million and $306 million , respectively.

Postretirement and Other Employ

Postretirement and Other Employee Benefits	9 Months Ended
	May 31, 2022
Retirement Benefits [Abstract]
Postretirement and Other Employee Benefits	Postretirement and Other Employee BenefitsNet Periodic Benefit Cost The following table provides information about the net periodic benefit cost (credit) for all plans for the three months and nine months ended May 31, 2022 and 2021 (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Service cost (1) $ 7 $ 6 $ 19 $ 19 Interest cost (2) 1 2 3 4 Expected long-term return on plan assets (2) (5) (4) (13) (12) Recognized actuarial gain (2) (2) (1) (8) (4) Amortization of actuarial gain (2)(3) (2) (2) (6) (5) Amortization of prior service cost (2) 1 — 3 — Net periodic benefit cost (credit) $ — $ 1 $ (2) $ 2 (1) Service cost is recognized in cost of revenue in the Condensed Consolidated Statement of Operations. (2) Components are recognized in other expense in the Condensed Consolidated Statement of Operations. (3) Actuarial gains and losses are amortized using a corridor approach. The gain/loss corridor is equal to 10 percent of the greater of the projected benefit obligation and the fair value of plan assets. Gains and losses in excess of the corridor are generally amortized over the average future working lifetime of the plan participants.

Derivative Financial Instrument

Derivative Financial Instruments and Hedging Activities	9 Months Ended
	May 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments and Hedging Activities	Derivative Financial Instruments and Hedging Activities The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company’s financial performance and are referred to as market risks. The Company, where deemed appropriate, uses derivatives as risk management tools to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency risk and interest rate risk. Foreign Currency Risk Management Forward contracts are put in place to manage the foreign currency risk associated with the anticipated foreign currency denominated revenues and expenses. A hedging relationship existed with an aggregate notional amount outstanding of $1.3 billion and $1.5 billion as of May 31, 2022 and August 31, 2021, respectively. The related forward foreign exchange contracts have been designated as hedging instruments and are accounted for as cash flow hedges. The forward foreign exchange contract transactions will effectively lock in the value of anticipated foreign currency denominated revenues and expenses against foreign currency fluctuations. The anticipated foreign currency denominated revenues and expenses being hedged are expected to occur between June 1, 2022 and May 31, 2023. In addition to derivatives that are designated as hedging instruments and qualify for hedge accounting, the Company also enters into forward contracts to economically hedge transactional exposure associated with commitments arising from trade accounts receivable, trade accounts payable, fixed purchase obligations and intercompany transactions denominated in a currency other than the functional currency of the respective operating entity. The aggregate notional amount of these outstanding contracts as of May 31, 2022 and August 31, 2021, was $3.1 billion and $3.6 billion, respectively. Refer to Note 15 – “Fair Value Measurements” for the fair values and classification of the Company’s derivative instruments. The gains and losses recognized in earnings due to amounts excluded from effectiveness testing were not material for all periods presented and are included as components of net revenue, cost of revenue and selling, general and administrative expense, which are the same line items in which the hedged items are recorded. The following table presents the net (losses) gains from forward contracts recorded in the Condensed Consolidated Statements of Operations for the periods indicated (in millions): Derivatives Not Designated as Hedging Instruments Under ASC 815 Location of (Loss) Gain on Derivatives Recognized in Net Income Amount of (Loss) Gain Recognized in Net Income on Derivatives Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Forward foreign exchange contracts (1) Cost of revenue $ (66) $ 27 $ (6) $ 148 (1) For the three months and nine months ended May 31, 2022, the Company recognized $64 million and $27 million, respectively, of foreign currency gains in cost of revenue, which are offset by the losses from the forward foreign exchange contracts. For the three months and nine months ended May 31, 2021, the Company recognized $22 million and $121 million, respectively, of foreign currency losses in cost of revenue, which are offset by the gains from the forward foreign exchange contracts. Interest Rate Risk Management The Company periodically enters into interest rate swaps to manage interest rate risk associated with the Company’s borrowings or anticipated debt issuances. Cash Flow Hedges The following table presents the interest rate swaps outstanding as of May 31, 2022, which have been designated as hedging instruments and are accounted for as cash flow hedges: Interest Rate Swap Summary Hedged Interest Rate Payments Aggregate Notional Amount (in millions) Effective Date Expiration Date Forward Interest Rate Swap Anticipated Debt Issuance Fixed $ 150 May 24, 2021 July 31, 2024 (1)(2) (1) The contracts will be settled with the respective counterparties on a net basis at the expiration date for the forward interest rate swap. (2) If the anticipated debt issuance occurs before July 31, 2024, the contracts will be terminated simultaneously with the debt issuance. Contemporaneously with the issuance of the 4.250% Senior Notes, in April 2022 the Company settled cash flow hedges with an aggregate notional amount of $250 million and $170 million, with effective dates of November 2020 and March 2022, respectively. The cash received for the cash flow hedges at settlement was $46 million. The settled cash flow hedges are recorded in the Condensed Consolidated Balance Sheets as a component of accumulated other comprehensive income (“AOCI”) and are amortized to interest expense in the Condensed Consolidated Statements of Operations. Contemporaneously with the issuance of the 3.000% Senior Notes in July 2020, the Company amended interest rate swap agreements with a notional amount of $200 million, with mandatory termination dates from August 15, 2020 to February 15, 2022 (the “2020 Extended Interest Rate Swaps”). In addition, the Company entered into interest rate swaps to offset future exposures of fluctuations in the fair value of the 2020 Extended Interest Rate Swaps (the “Offsetting Interest Rate Swaps”). The change in fair value of the 2020 Extended Interest Rate Swaps and Offsetting Interest Rate Swaps was recorded in the Condensed Consolidated Statements of Operations through the maturity date of February 15, 2022, as an adjustment to interest expense.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	9 Months Ended
	May 31, 2022
Equity [Abstract]
Accumulated Other Comprehensive Income	Accumulated Other Comprehensive Income The following table sets forth the changes in AOCI, net of tax, by component for the nine months ended May 31, 2022 (in millions): Foreign Derivative Actuarial Prior Total Balance as of August 31, 2021 $ (20) $ (36) $ 51 $ (20) $ (25) Other comprehensive (loss) income before reclassifications (20) 31 (1) — 10 Amounts reclassified from AOCI — 6 (14) 3 (5) Other comprehensive (loss) income (1) (20) 37 (15) 3 5 Balance as of May 31, 2022 $ (40) $ 1 $ 36 $ (17) $ (20) (1) Amounts are net of tax, which are immaterial. The following table sets forth the amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, net of tax, for the periods indicated (in millions): Three months ended Nine months ended Comprehensive Income Components Financial Statement Line Item May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Realized losses (gains) on derivative instruments: (1) Foreign exchange contracts Cost of revenue $ 9 $ (4) $ 4 $ (43) Interest rate contracts Interest expense — — 2 2 Actuarial gain (2) (4) — (14) — Prior service cost (2) 1 — 3 — Total amounts reclassified from AOCI (3) $ 6 $ (4) $ (5) $ (41) (1) The Company expects to reclassify $20 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue. (2) Amounts are included in the computation of net periodic benefit cost (credit). Refer to Note 8 – “Postretirement and Other Employee Benefits” for additional information. (3) Amounts are net of tax, which are immaterial for the three months and nine months ended May 31, 2022 and 2021.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	May 31, 2022
Share-based Payment Arrangement [Abstract]
Stockholders' Equity	Stockholders’ Equity The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Restricted stock units $ 13 $ 16 $ 57 $ 68 Employee stock purchase plan 3 3 10 8 Total $ 16 $ 19 $ 67 $ 76 As of May 31, 2022, the shares available to be issued under the 2021 Equity Incentive Plan w ere 9,940,536. Restricted Stock Units Certain key employees have been granted time-based, performance-based and market-based restricted stock unit awards (“restricted stock units”). The time-based restricted stock units generally vest on a graded vesting schedule over three years. T he performance-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 150%, depending on the specified performance condition and the level of achievement obtained. The performance-based restricted stock units have a vesting condition that is based upon the Company’s cumulative adjusted core earnings per share during the performance period. The market-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 200% , depending on the specified performance condition and the level of achievement obtained. The market-based restricted stock units ha ve a vesting condition that is tied to the Company’s total shareholder return based on the Company’s stock performance in relation to the companies in the Standard and Poor’s (S&P) Super Composite Technology Hardware and Equipment Index excluding the Company. During the nine months ended May 31, 2022 and 2021, the Company awarded approximately 0.7 million and 1.2 million time-based restricted stock units, respectively, 0.2 million and 0.4 million performance-based restricted stock units, respectively, and 0.2 million and 0.3 million market-based restricted stock units, respectively. The following represents the stock-based compensation information as of the period indicated (in millions): May 31, 2022 Unrecognized stock-based compensation expense—restricted stock units $ 44 Remaining weighted-average period for restricted stock units expense 1.5 years Common Stock Outstanding The following represents the common stock outstanding for the periods indicated: Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Common stock outstanding: Beginning balances 142,392,135 149,366,501 144,496,077 150,330,358 Shares issued upon exercise of stock options — 9,321 — 9,321 Shares issued under employee stock purchase plan 1,686 — 522,169 771,548 Vesting of restricted stock 13,609 12,787 2,467,324 2,253,923 Purchases of treasury stock under employee stock plans (3,766) (3,436) (704,040) (613,715) Treasury shares purchased (1) (3,552,475) (2,547,707) (7,930,341) (5,913,969) Ending balances 138,851,189 146,837,466 138,851,189 146,837,466

Concentration of Risk and Segme

Concentration of Risk and Segment Data	9 Months Ended
	May 31, 2022
Segment Reporting [Abstract]
Concentration of Risk and Segment Data	Concentration of Risk and Segment Data Concentration of Risk Sales of the Company’s products are concentrated among specific customers. During the nine months ended May 31, 2022, the Company’s five largest customers accounted for approximately 45% of its net revenue and 79 customers accounted for approximately 90% of its net revenue. Sales to these customers were reported in the Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”) operating segments. The Company procures components from a broad group of suppliers. Some of the products manufactured by the Company require one or more components that are available from only a single source. Segment Data Net revenue for the operating segments is attributed to the segment in which the service is performed. An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net revenue less cost of revenue, segment selling, general and administrative expenses, segment research and development expenses and an allocation of corporate manufacturing expenses and selling, general and administrative expenses. Certain items are excluded from the calculation of segment income. Transactions between operating segments are generally recorded at amounts that approximate those at which we would transact with third parties. The following table sets forth operating segment information (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Segment income and reconciliation of income before income tax EMS $ 208 $ 137 $ 507 $ 357 DMS 144 140 589 570 Total segment income $ 352 $ 277 $ 1,096 $ 927 Reconciling items: Amortization of intangibles (8) (12) (24) (35) Stock-based compensation expense and related charges (16) (19) (67) (76) Restructuring, severance and related charges — (1) — (6) Business interruption and impairment charges, net — — — 1 Acquisition and integration charges — — — (4) Loss on debt extinguishment (4) — (4) — Gain on securities — 2 — 2 Other expense (net of periodic benefit cost) (8) (1) (19) (10) Interest income 1 1 2 5 Interest expense (39) (34) (105) (97) Income before income tax $ 278 $ 213 $ 879 $ 707 The following table presents the Company’s revenues disaggregated by segment (in millions): Three months ended May 31, 2022 May 31, 2021 EMS DMS Total EMS DMS Total Timing of transfer Point in time $ 1,755 $ 1,395 $ 3,150 $ 1,346 $ 1,441 $ 2,787 Over time 2,736 2,442 5,178 2,297 2,131 4,428 Total $ 4,491 $ 3,837 $ 8,328 $ 3,643 $ 3,572 $ 7,215 Nine months ended May 31, 2022 May 31, 2021 EMS DMS Total EMS DMS Total Timing of transfer Point in time $ 4,489 $ 5,183 $ 9,672 $ 3,222 $ 5,463 $ 8,685 Over time 7,634 7,142 14,776 7,193 5,998 13,191 Total $ 12,123 $ 12,325 $ 24,448 $ 10,415 $ 11,461 $ 21,876 The Company operates in more than 30 countries worldwide. Sales to unaffiliated customers are based on the Company location that maintains the customer relationship and transacts the external sale. The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue: Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Foreign source revenue 82.6 % 82.7 % 83.7 % 83.6 %

Income Taxes

Income Taxes	9 Months Ended
	May 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Effective Income Tax Rate The U.S. federal statutory income tax rate and the Company's effective income tax rate are as follows: Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 U.S. federal statutory income tax rate 21.0 % 21.0 % 21.0 % 21.0 % Effective income tax rate 21.8 % 20.3 % 22.5 % 26.0 % The effective income tax rate differed for the three months and nine months ended May 31, 2022, compared to the three months and nine months ended May 31, 2021, primarily due to: (i) decreased losses in tax jurisdictions with existing valuation allowances for the three months and nine months ended May 31, 2022 and (ii) a $17 million income tax expense during the three months ended May 31, 2022 for an unrecognized tax benefit related to the taxation of certain prior year intercompany transactions. The effective income tax rate differed from the U.S. federal statutory income tax rate of 21.0% during the three months and nine months ended May 31, 2022 and 2021, primarily due to: (i) losses in tax jurisdictions with existing valuation allowances, (ii) tax incentives granted to sites in China, Malaysia, Singapore and Vietnam, and (iii) a $17 million income tax expense during the three months ended May 31, 2022 for an unrecognized tax benefit related to the taxation of certain prior year intercompany transactions.

Earnings Per Share and Dividend

Earnings Per Share and Dividends	9 Months Ended
	May 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share and Dividends	Earnings Per Share and Dividends Earnings Per Share The Company calculates its basic earnings per share by dividing net income attributable to the Company by the weighted average number of common shares outstanding during the period. The Company’s diluted earnings per share is calculated in a similar manner, but includes the effect of dilutive securities. The difference between the weighted average number of basic shares outstanding and the weighted average number of diluted shares outstanding is primarily due to dilutive unvested restricted stock units. Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be antidilutive. Performance-based restricted stock units are considered dilutive when the related performance criteria have been met assuming the end of the reporting period represents the end of the performance period. All potential shares of common stock are antidilutive in periods of net loss. Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Restricted stock units 430.9 665.0 431.7 665.0 Dividends The following table sets forth cash dividends declared by the Company to common stockholders during the nine months ended May 31, 2022 and 2021 (in millions, except for per share data): Dividend Dividend Total of Cash Date of Record for Dividend Cash Fiscal Year 2022: October 21, 2021 $ 0.08 $ 12 November 15, 2021 December 1, 2021 January 20, 2022 $ 0.08 $ 12 February 15, 2022 March 2, 2022 April 21, 2022 $ 0.08 $ 12 May 16, 2022 June 2, 2022 Fiscal Year 2021: October 15, 2020 $ 0.08 $ 12 November 16, 2020 December 2, 2020 January 21, 2021 $ 0.08 $ 12 February 15, 2021 March 2, 2021 April 22, 2021 $ 0.08 $ 12 May 14, 2021 June 2, 2021

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	May 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair Value Measurements on a Recurring Basis The following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated (in millions): Fair Value Hierarchy May 31, 2022 August 31, 2021 Assets: Cash and cash equivalents: Cash equivalents Level 1 (1) $ 10 $ 36 Prepaid expenses and other current assets: Short-term investments Level 1 17 18 Forward foreign exchange contracts: Derivatives designated as hedging instruments (Note 9) Level 2 (2) 8 9 Derivatives not designated as hedging instruments (Note 9) Level 2 (2) 18 20 Other assets: Forward interest rate swap: Derivatives designated as hedging instruments (Note 9) Level 2 (3) 9 9 Liabilities: Accrued expenses: Forward foreign exchange contracts: Derivatives designated as hedging instruments (Note 9) Level 2 (2) $ 25 $ 6 Derivatives not designated as hedging instruments (Note 9) Level 2 (2) 56 9 Interest rate swaps: Derivatives not designated as hedging instruments (Note 9) Level 2 (3) — 3 Extended interest rate swap not designated as a hedging instrument (Note 9) Level 2 (4) — 10 Other liabilities: Forward interest rate swap: Derivatives designated as hedging instruments (Note 9) Level 2 (3) — 7 (1) Consist of investments that are readily convertible to cash with original maturities of 90 days or less. (2) The Company’s forward foreign exchange contracts are measured on a recurring basis at fair value, based on foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. (3) Fair value measurements are based on the contractual terms of the derivatives and use observable market-based inputs. The interest rate swaps are valued using a discounted cash flow analysis on the expected cash flows of each derivative using observable inputs including interest rate curves and credit spreads. (4) The 2020 Extended Interest Rate Swaps were considered a hybrid instrument and the Company elected the fair value option for reporting. Fair value measurements were based on the contractual terms of the contract and used observable market-based inputs. The interest rate swaps were valued using a discounted cash flow analysis of the expected cash flows using observable inputs including interest rate curves and credit spreads. Assets Held for Sale The following table presents the assets held for sale (in millions): May 31, 2022 August 31, 2021 Carrying Amount Carrying Amount Assets held for sale (1) $ — $ 61 (1) During the nine months ended May 31, 2022, the Company sold assets held for sale with a carrying value of $61 million. Fair Value of Financial Instruments The carrying amounts of cash and cash equivalents, trade accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value because of the short-term nature of these financial instruments. The carrying amounts of borrowings under credit facilities and under loans approximates fair value as interest rates on these instruments approximates current market rates. Notes payable and long-term debt is carried at amortized cost; however, the Company estimates the fair values of notes payable and long-term debt for disclosure purposes. The following table presents the carrying amounts and fair values of the Company's notes payable and long-term debt, by hierarchy level as of the periods indicated (in millions): May 31, 2022 August 31, 2021 Fair Value Hierarchy Carrying Amount Fair Value Carrying Amount Fair Value Notes payable and long-term debt: (Note 5) 4.700% Senior Notes Level 2 (1) $ — $ — $ 499 $ 521 4.900% Senior Notes Level 3 (2) $ 300 $ 305 $ 300 $ 322 3.950% Senior Notes Level 2 (1) $ 497 $ 492 $ 496 $ 555 3.600% Senior Notes Level 2 (1) $ 496 $ 459 $ 495 $ 541 3.000% Senior Notes Level 2 (1) $ 592 $ 522 $ 591 $ 618 1.700% Senior Notes Level 2 (1) $ 496 $ 455 $ 496 $ 504 4.250% Senior Notes Level 2 (1) $ 493 $ 497 $ — $ — (1) The fair value estimates are based upon observable market data.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	May 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Proceedings The Company is party to certain lawsuits in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial position, results of operations or cash flows.

New Accounting Guidance

New Accounting Guidance	9 Months Ended
	May 31, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Guidance	New Accounting Guidance New accounting guidance adopted during the period did not have a material impact to the Company. Recently issued accounting guidance is not applicable or did not have, or is not expected to have, a material impact to the Company.

New Accounting Guidance (Polici

New Accounting Guidance (Policies)	9 Months Ended
	May 31, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
New and Recently Issued Accounting Guidance	New accounting guidance adopted during the period did not have a material impact to the Company. Recently issued accounting guidance is not applicable or did not have, or is not expected to have, a material impact to the Company.

Trade Accounts Receivable Sal_2

Trade Accounts Receivable Sale Programs (Tables)	9 Months Ended
	May 31, 2022
Transfers and Servicing [Abstract]
Schedule of Trade Accounts Receivable Sale Programs Amounts Recognized	In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Trade accounts receivable sold (1) $ 2,575 $ 1,016 $ 6,509 $ 3,567 Cash proceeds received $ 2,572 $ 1,015 $ 6,504 $ 3,565 Pre-tax losses on sale of receivables (2) $ 3 $ 1 $ 5 $ 2 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) Recorded to other expense within the Condensed Consolidated Statement of Operations.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	May 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consist of the following (in millions): May 31, 2022 August 31, 2021 Raw materials $ 4,722 $ 3,142 Work in process 699 677 Finished goods 646 680 Reserve for excess and obsolete inventory (86) (85) Inventories, net $ 5,981 $ 4,414

Leases (Tables)

Leases (Tables)	9 Months Ended
	May 31, 2022
Leases [Abstract]
Schedule of Future Minimum Lease Payments under Operating Leases	The future minimum lease payments under these new leases as of May 31, 2022 were as follows (in millions): Payments due by period Total Less than 1 1-3 years 3-5 years After 5 years Operating lease obligations (1) $ 180 $ 31 $ 56 $ 44 $ 49 Finance lease obligations (1) $ 74 $ 37 $ 36 $ 1 $ — (1) Excludes $33 million of payments related to leases signed but not yet commenced. Additionally, certain leases signed but not yet commenced contain residual value guarantees and purchase options not deemed probable.
Schedule of Future Minimum Lease Payments under Finance Leases	The future minimum lease payments under these new leases as of May 31, 2022 were as follows (in millions): Payments due by period Total Less than 1 1-3 years 3-5 years After 5 years Operating lease obligations (1) $ 180 $ 31 $ 56 $ 44 $ 49 Finance lease obligations (1) $ 74 $ 37 $ 36 $ 1 $ — (1) Excludes $33 million of payments related to leases signed but not yet commenced. Additionally, certain leases signed but not yet commenced contain residual value guarantees and purchase options not deemed probable.

Notes Payable and Long-Term D_2

Notes Payable and Long-Term Debt (Tables)	9 Months Ended
	May 31, 2022
Debt Disclosure [Abstract]
Schedule of Notes Payable and Long-term Debt	Notes payable and long-term debt outstanding as of May 31, 2022 and August 31, 2021 are summarized below (in millions): Maturity Date May 31, 2022 August 31, 2021 4.700% Senior Notes (1) Sep 15, 2022 $ — $ 499 4.900% Senior Notes Jul 14, 2023 300 300 3.950% Senior Notes Jan 12, 2028 497 496 3.600% Senior Notes Jan 15, 2030 496 495 3.000% Senior Notes Jan 15, 2031 592 591 1.700% Senior Notes Apr 15, 2026 496 496 4.250% Senior Notes (1) May 15, 2027 493 — Borrowings under credit facilities (2) Jan 22, 2024 and Jan 22, 2026 — — Borrowings under loans Jul 31, 2026 1 1 Total notes payable and long-term debt 2,875 2,878 Less current installments of notes payable and long-term debt 1 — Notes payable and long-term debt, less current installments $ 2,874 $ 2,878 (1) On May 4, 2022, the Company issued $500 million of registered 4.250% Senior Notes due 2027 (the “Green Bonds” or the “4.250% Senior Notes”). On May 31, 2022, the net proceeds from the offering were used to redeem the Company’s 4.700% Senior Notes due in 2022 and pay the applicable “make-whole” premium and accrued interest. In addition, the Company intends to allocate an amount equal to the net proceeds from this offering to finance or refinance eligible expenditures under the Company’s new green financing framework. (2) As of May 31, 2022, the Company has $3.8 billion in available unused borrowing capacity under its revolving credit facilities. The senior unsecured credit agreement dated as of January 22, 2020 and amended on April 28, 2021 (the “Credit Facility”) acts as the back-up facility for commercial paper outstanding, if any. The Company has a borrowing capacity of up to $3.2 billion under its commercial paper program, which was increased from $1.8 billion on February 18, 2022.

Asset-Backed Securitization P_2

Asset-Backed Securitization Program (Tables)	9 Months Ended
	May 31, 2022
Transfers and Servicing [Abstract]
Schedule of Asset-backed Securitization Programs Amounts Recognized	In connection with the asset-backed securitization programs, the Company recognized the following (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 (4) May 31, 2022 May 31, 2021 (4) Trade accounts receivable sold (1) $ 947 $ 1,074 $ 2,979 $ 3,388 Cash proceeds received (2) $ 942 $ 1,072 $ 2,971 $ 3,381 Pre-tax losses on sale of receivables (3) $ 5 $ 2 $ 8 $ 7 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) The amounts primarily represent proceeds from collections reinvested in revolving-period transfers. (3) Recorded to other expense within the Condensed Consolidated Statements of Operations. (4) Activity includes the foreign asset-backed securitization program which terminated on June 28, 2021.

Accrued Expenses (Tables)

Accrued Expenses (Tables)	9 Months Ended
	May 31, 2022
Accrued Liabilities, Current [Abstract]
Schedule of Accrued Expenses	Accrued expenses consist of the following (in millions): May 31, 2022 August 31, 2021 Inventory deposits $ 1,254 $ 711 Contract liabilities (1) 733 559 Accrued compensation and employee benefits 729 827 Other accrued expenses 2,028 1,637 Accrued expenses $ 4,744 $ 3,734 (1) Revenue recognized during the nine months ended May 31, 2022 and 2021 that was included in the contract liability balance as of August 31, 2021 and 2020 was $269 million and $306 million , respectively.

Postretirement and Other Empl_2

Postretirement and Other Employee Benefits (Tables)	9 Months Ended
	May 31, 2022
Retirement Benefits [Abstract]
Schedule of Information about Net Periodic Benefit Cost (Credit) for Plans	The following table provides information about the net periodic benefit cost (credit) for all plans for the three months and nine months ended May 31, 2022 and 2021 (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Service cost (1) $ 7 $ 6 $ 19 $ 19 Interest cost (2) 1 2 3 4 Expected long-term return on plan assets (2) (5) (4) (13) (12) Recognized actuarial gain (2) (2) (1) (8) (4) Amortization of actuarial gain (2)(3) (2) (2) (6) (5) Amortization of prior service cost (2) 1 — 3 — Net periodic benefit cost (credit) $ — $ 1 $ (2) $ 2 (1) Service cost is recognized in cost of revenue in the Condensed Consolidated Statement of Operations. (2) Components are recognized in other expense in the Condensed Consolidated Statement of Operations. (3) Actuarial gains and losses are amortized using a corridor approach. The gain/loss corridor is equal to 10 percent of the greater of the projected benefit obligation and the fair value of plan assets. Gains and losses in excess of the corridor are generally amortized over the average future working lifetime of the plan participants.

Derivative Financial Instrume_2

Derivative Financial Instruments and Hedging Activities (Tables)	9 Months Ended
	May 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Net (Losses) Gains from Forward Contracts Recorded in Consolidated Statements of Operations	The following table presents the net (losses) gains from forward contracts recorded in the Condensed Consolidated Statements of Operations for the periods indicated (in millions): Derivatives Not Designated as Hedging Instruments Under ASC 815 Location of (Loss) Gain on Derivatives Recognized in Net Income Amount of (Loss) Gain Recognized in Net Income on Derivatives Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Forward foreign exchange contracts (1) Cost of revenue $ (66) $ 27 $ (6) $ 148
Schedule of Notional Amounts of Outstanding Derivative Positions	The following table presents the interest rate swaps outstanding as of May 31, 2022, which have been designated as hedging instruments and are accounted for as cash flow hedges: Interest Rate Swap Summary Hedged Interest Rate Payments Aggregate Notional Amount (in millions) Effective Date Expiration Date Forward Interest Rate Swap Anticipated Debt Issuance Fixed $ 150 May 24, 2021 July 31, 2024 (1)(2) (1) The contracts will be settled with the respective counterparties on a net basis at the expiration date for the forward interest rate swap. (2) If the anticipated debt issuance occurs before July 31, 2024, the contracts will be terminated simultaneously with the debt issuance.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	9 Months Ended
	May 31, 2022
Equity [Abstract]
Summary of Changes in AOCI	The following table sets forth the changes in AOCI, net of tax, by component for the nine months ended May 31, 2022 (in millions): Foreign Derivative Actuarial Prior Total Balance as of August 31, 2021 $ (20) $ (36) $ 51 $ (20) $ (25) Other comprehensive (loss) income before reclassifications (20) 31 (1) — 10 Amounts reclassified from AOCI — 6 (14) 3 (5) Other comprehensive (loss) income (1) (20) 37 (15) 3 5 Balance as of May 31, 2022 $ (40) $ 1 $ 36 $ (17) $ (20) (1) Amounts are net of tax, which are immaterial.
Summary of Reclassification from AOCI	The following table sets forth the amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, net of tax, for the periods indicated (in millions): Three months ended Nine months ended Comprehensive Income Components Financial Statement Line Item May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Realized losses (gains) on derivative instruments: (1) Foreign exchange contracts Cost of revenue $ 9 $ (4) $ 4 $ (43) Interest rate contracts Interest expense — — 2 2 Actuarial gain (2) (4) — (14) — Prior service cost (2) 1 — 3 — Total amounts reclassified from AOCI (3) $ 6 $ (4) $ (5) $ (41) (1) The Company expects to reclassify $20 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue. (2) Amounts are included in the computation of net periodic benefit cost (credit). Refer to Note 8 – “Postretirement and Other Employee Benefits” for additional information. (3) Amounts are net of tax, which are immaterial for the three months and nine months ended May 31, 2022 and 2021.

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	May 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Recognized Stock-based Compensation Expense	The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Restricted stock units $ 13 $ 16 $ 57 $ 68 Employee stock purchase plan 3 3 10 8 Total $ 16 $ 19 $ 67 $ 76
Schedule of Share-based Compensation Information	The following represents the stock-based compensation information as of the period indicated (in millions): May 31, 2022 Unrecognized stock-based compensation expense—restricted stock units $ 44 Remaining weighted-average period for restricted stock units expense 1.5 years
Schedule of Common Stock Outstanding	The following represents the common stock outstanding for the periods indicated: Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Common stock outstanding: Beginning balances 142,392,135 149,366,501 144,496,077 150,330,358 Shares issued upon exercise of stock options — 9,321 — 9,321 Shares issued under employee stock purchase plan 1,686 — 522,169 771,548 Vesting of restricted stock 13,609 12,787 2,467,324 2,253,923 Purchases of treasury stock under employee stock plans (3,766) (3,436) (704,040) (613,715) Treasury shares purchased (1) (3,552,475) (2,547,707) (7,930,341) (5,913,969) Ending balances 138,851,189 146,837,466 138,851,189 146,837,466

Concentration of Risk and Seg_2

Concentration of Risk and Segment Data (Tables)	9 Months Ended
	May 31, 2022
Segment Reporting [Abstract]
Schedule of Reconciliation of Income from Segments to Consolidated	The following table sets forth operating segment information (in millions): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Segment income and reconciliation of income before income tax EMS $ 208 $ 137 $ 507 $ 357 DMS 144 140 589 570 Total segment income $ 352 $ 277 $ 1,096 $ 927 Reconciling items: Amortization of intangibles (8) (12) (24) (35) Stock-based compensation expense and related charges (16) (19) (67) (76) Restructuring, severance and related charges — (1) — (6) Business interruption and impairment charges, net — — — 1 Acquisition and integration charges — — — (4) Loss on debt extinguishment (4) — (4) — Gain on securities — 2 — 2 Other expense (net of periodic benefit cost) (8) (1) (19) (10) Interest income 1 1 2 5 Interest expense (39) (34) (105) (97) Income before income tax $ 278 $ 213 $ 879 $ 707
Schedule of Revenues Disaggregated by Segment	The following table presents the Company’s revenues disaggregated by segment (in millions): Three months ended May 31, 2022 May 31, 2021 EMS DMS Total EMS DMS Total Timing of transfer Point in time $ 1,755 $ 1,395 $ 3,150 $ 1,346 $ 1,441 $ 2,787 Over time 2,736 2,442 5,178 2,297 2,131 4,428 Total $ 4,491 $ 3,837 $ 8,328 $ 3,643 $ 3,572 $ 7,215 Nine months ended May 31, 2022 May 31, 2021 EMS DMS Total EMS DMS Total Timing of transfer Point in time $ 4,489 $ 5,183 $ 9,672 $ 3,222 $ 5,463 $ 8,685 Over time 7,634 7,142 14,776 7,193 5,998 13,191 Total $ 12,123 $ 12,325 $ 24,448 $ 10,415 $ 11,461 $ 21,876
Schedule of Revenue from External Customers by Geographic Areas	The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue: Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Foreign source revenue 82.6 % 82.7 % 83.7 % 83.6 %

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	May 31, 2022
Income Tax Disclosure [Abstract]
Schedule of U.S. Federal Statutory Income Tax Rate Compared to Actual Income Tax Expense	The U.S. federal statutory income tax rate and the Company's effective income tax rate are as follows: Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 U.S. federal statutory income tax rate 21.0 % 21.0 % 21.0 % 21.0 % Effective income tax rate 21.8 % 20.3 % 22.5 % 26.0 %

Earnings Per Share and Divide_2

Earnings Per Share and Dividends (Tables)	9 Months Ended
	May 31, 2022
Earnings Per Share [Abstract]
Schedule of Dilutive Shares Outstanding Not Included in the Computation of EPS	Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands): Three months ended Nine months ended May 31, 2022 May 31, 2021 May 31, 2022 May 31, 2021 Restricted stock units 430.9 665.0 431.7 665.0
Schedule of Cash Dividends Declared to Common Stockholders	The following table sets forth cash dividends declared by the Company to common stockholders during the nine months ended May 31, 2022 and 2021 (in millions, except for per share data): Dividend Dividend Total of Cash Date of Record for Dividend Cash Fiscal Year 2022: October 21, 2021 $ 0.08 $ 12 November 15, 2021 December 1, 2021 January 20, 2022 $ 0.08 $ 12 February 15, 2022 March 2, 2022 April 21, 2022 $ 0.08 $ 12 May 16, 2022 June 2, 2022 Fiscal Year 2021: October 15, 2020 $ 0.08 $ 12 November 16, 2020 December 2, 2020 January 21, 2021 $ 0.08 $ 12 February 15, 2021 March 2, 2021 April 22, 2021 $ 0.08 $ 12 May 14, 2021 June 2, 2021

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	May 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Financial Assets and Liabilities	The following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated (in millions): Fair Value Hierarchy May 31, 2022 August 31, 2021 Assets: Cash and cash equivalents: Cash equivalents Level 1 (1) $ 10 $ 36 Prepaid expenses and other current assets: Short-term investments Level 1 17 18 Forward foreign exchange contracts: Derivatives designated as hedging instruments (Note 9) Level 2 (2) 8 9 Derivatives not designated as hedging instruments (Note 9) Level 2 (2) 18 20 Other assets: Forward interest rate swap: Derivatives designated as hedging instruments (Note 9) Level 2 (3) 9 9 Liabilities: Accrued expenses: Forward foreign exchange contracts: Derivatives designated as hedging instruments (Note 9) Level 2 (2) $ 25 $ 6 Derivatives not designated as hedging instruments (Note 9) Level 2 (2) 56 9 Interest rate swaps: Derivatives not designated as hedging instruments (Note 9) Level 2 (3) — 3 Extended interest rate swap not designated as a hedging instrument (Note 9) Level 2 (4) — 10 Other liabilities: Forward interest rate swap: Derivatives designated as hedging instruments (Note 9) Level 2 (3) — 7 (1) Consist of investments that are readily convertible to cash with original maturities of 90 days or less. (2) The Company’s forward foreign exchange contracts are measured on a recurring basis at fair value, based on foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. (3) Fair value measurements are based on the contractual terms of the derivatives and use observable market-based inputs. The interest rate swaps are valued using a discounted cash flow analysis on the expected cash flows of each derivative using observable inputs including interest rate curves and credit spreads.
Schedule of Assets Held for Sale	The following table presents the assets held for sale (in millions): May 31, 2022 August 31, 2021 Carrying Amount Carrying Amount Assets held for sale (1) $ — $ 61 (1) During the nine months ended May 31, 2022, the Company sold assets held for sale with a carrying value of $61 million.
Schedule of Carrying Amounts and Fair Values of Notes Payable and Long-term Debt	The following table presents the carrying amounts and fair values of the Company's notes payable and long-term debt, by hierarchy level as of the periods indicated (in millions): May 31, 2022 August 31, 2021 Fair Value Hierarchy Carrying Amount Fair Value Carrying Amount Fair Value Notes payable and long-term debt: (Note 5) 4.700% Senior Notes Level 2 (1) $ — $ — $ 499 $ 521 4.900% Senior Notes Level 3 (2) $ 300 $ 305 $ 300 $ 322 3.950% Senior Notes Level 2 (1) $ 497 $ 492 $ 496 $ 555 3.600% Senior Notes Level 2 (1) $ 496 $ 459 $ 495 $ 541 3.000% Senior Notes Level 2 (1) $ 592 $ 522 $ 591 $ 618 1.700% Senior Notes Level 2 (1) $ 496 $ 455 $ 496 $ 504 4.250% Senior Notes Level 2 (1) $ 493 $ 497 $ — $ — (1) The fair value estimates are based upon observable market data.

Trade Accounts Receivable Sal_3

Trade Accounts Receivable Sale Programs (Additional Information) (Details) - 9 months ended May 31, 2022	USD ($) program	CNY (¥)	CHF (SFr)
USD
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount | $	$ 2,000,000,000
Number of programs	9
CNY
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount | ¥		¥ 400,000,000
Number of programs	1
CHF
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount | SFr			SFr 100,000,000
Number of programs	1

Trade Accounts Receivable Sal_4

Trade Accounts Receivable Sale Programs (Trade Accounts Receivable Sale Programs Amounts Recognized) (Details) - Trade Accounts Receivable Sale Programs - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Trade accounts receivable sold	$ 2,575	$ 1,016	$ 6,509	$ 3,567
Cash proceeds received	2,572	1,015	6,504	3,565
Pre-tax losses on sale of receivables	$ 3	$ 1	$ 5	$ 2

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	May 31, 2022	Aug. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 4,722	$ 3,142
Work in process	699	677
Finished goods	646	680
Reserve for excess and obsolete inventory	(86)	(85)
Inventories, net	$ 5,981	$ 4,414

Leases (Future Minimum Lease Pa

Leases (Future Minimum Lease Payments under Operating and Finance Leases) (Details) $ in Millions	May 31, 2022 USD ($)
Operating Leases
Minimum lease payments	$ 180
Less than 1 year	31
1-3 years	56
3-5 years	44
After 5 years	49
Finance Leases
Minimum lease payments	74
Less than 1 year	37
1-3 years	36
3-5 years	1
After 5 years	0
Leases signed but not yet commenced	$ 33

Notes Payable and Long-Term D_3

Notes Payable and Long-Term Debt (Schedule of Notes Payable and Long-term Debt) (Details) - USD ($)	May 31, 2022	May 04, 2022	Feb. 18, 2022	Feb. 17, 2022	Aug. 31, 2021	Jul. 31, 2020
Debt Instrument [Line Items]
Long-term debt	$ 2,875,000,000				$ 2,878,000,000
Less current installments of notes payable and long-term debt	1,000,000				0
Notes payable and long-term debt, less current installments	$ 2,874,000,000				2,878,000,000
Senior Notes | 4.700% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	4.70%
Long-term debt	$ 0				499,000,000
Senior Notes | 4.900% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	4.90%
Long-term debt	$ 300,000,000				300,000,000
Senior Notes | 3.950% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	3.95%
Long-term debt	$ 497,000,000				496,000,000
Senior Notes | 3.600% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	3.60%
Long-term debt	$ 496,000,000				495,000,000
Senior Notes | 3.000% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	3%					3%
Long-term debt	$ 592,000,000				591,000,000
Senior Notes | 1.700% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	1.70%
Long-term debt	$ 496,000,000				496,000,000
Senior Notes | 4.250% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	4.25%	4.25%
Long-term debt	$ 493,000,000				0
Debt issuance		$ 500,000,000
Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term debt	0				0
Unused borrowing capacity	3,800,000,000
Line of Credit | Term Loan Facility
Debt Instrument [Line Items]
Long-term debt	$ 1,000,000				$ 1,000,000
Line of Credit | Commercial Paper
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 3,200,000,000	$ 1,800,000,000

Notes Payable and Long-Term D_4

Notes Payable and Long-Term Debt (Additional Information) (Details) - Senior Notes	May 31, 2022	May 04, 2022	Jul. 31, 2020
4.900% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	4.90%
4.700% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	4.70%
3.950% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	3.95%
3.600% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	3.60%
3.000% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	3%		3%
1.700% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	1.70%
4.250% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	4.25%	4.25%

Asset-Backed Securitization P_3

Asset-Backed Securitization Program (Additional Information) (Details)	May 31, 2022 USD ($)
Transfers and Servicing [Abstract]
Maximum amount of net cash proceeds	$ 600,000,000
Available liquidity under its asset-backed securitization programs (up to)	$ 0

Asset-Backed Securitization P_4

Asset-Backed Securitization Program (Securitization Activity) (Details) - Asset-Backed Securitization Program - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Trade accounts receivable sold	$ 947	$ 1,074	$ 2,979	$ 3,388
Cash proceeds received	942	1,072	2,971	3,381
Pre-tax losses on sale of receivables	$ 5	$ 2	$ 8	$ 7

Accrued Expenses (Details)

Accrued Expenses (Details) - USD ($) $ in Millions	9 Months Ended
	May 31, 2022	May 31, 2021	Aug. 31, 2021
Accrued Liabilities, Current [Abstract]
Inventory deposits	$ 1,254		$ 711
Contract liabilities	733		559
Accrued compensation and employee benefits	729		827
Other accrued expenses	2,028		1,637
Accrued expenses	4,744		$ 3,734
Revenue recognized during period that was included in contract liability balance	$ 269	$ 306

Postretirement and Other Empl_3

Postretirement and Other Employee Benefits (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Retirement Benefits [Abstract]
Service cost	$ 7	$ 6	$ 19	$ 19
Interest cost	1	2	3	4
Expected long-term return on plan assets	(5)	(4)	(13)	(12)
Recognized actuarial gain	(2)	(1)	(8)	(4)
Amortization of actuarial gains	(2)	(2)	(6)	(5)
Amortization of prior service credit	1	0	3	0
Net periodic benefit cost (credit)	$ 0	$ 1	$ (2)	$ 2

Derivative Financial Instrume_3

Derivative Financial Instruments and Hedging Activities (Additional Information) (Details) - USD ($)	1 Months Ended
	Apr. 30, 2022	May 31, 2022	May 04, 2022	Aug. 31, 2021	Jul. 31, 2020
4.250% Senior Notes | Senior Notes
Derivative [Line Items]
Stated interest rate (as a percent)		4.25%	4.25%
3.000% Senior Notes | Senior Notes
Derivative [Line Items]
Stated interest rate (as a percent)		3%			3%
Cash flow hedging
Derivative [Line Items]
Cash received at settlement	$ 46,000,000
Cash flow hedging | Interest rate swaps | 3.000% Senior Notes
Derivative [Line Items]
Aggregate notional amount					$ 200,000,000
Cash flow hedging | Settled cash flow hedge, effective date November 2020
Derivative [Line Items]
Aggregate notional amount	250,000,000
Cash flow hedging | Settled cash flow hedge, effective date March 2022
Derivative [Line Items]
Aggregate notional amount	$ 170,000,000
Forward Interest Rate Swap | Forward foreign exchange contracts
Derivative [Line Items]
Aggregate notional amount		$ 1,300,000,000		$ 1,500,000,000
Forward Interest Rate Swap | Cash flow hedging
Derivative [Line Items]
Aggregate notional amount		$ 3,100,000,000		$ 3,600,000,000

Derivative Financial Instrume_4

Derivative Financial Instruments and Hedging Activities (Fair Value of Derivative Instruments Recorded on Consolidated Statements of Operations) (Details) - Forward foreign exchange contracts - Cost of revenue - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss) Gain Recognized in Net Income on Derivatives	$ (66)	$ 27	$ (6)	$ 148
Foreign currency gains	$ 64	$ 22	$ 27	$ 121

Derivative Financial Instrume_5

Derivative Financial Instruments and Hedging Activities (Cash Flow Hedges) (Details)	May 31, 2022 USD ($)
Cash flow hedging | Interest rate swaps | Designated as hedging instruments
Derivative [Line Items]
Aggregate notional amount	$ 150,000,000

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Change in AOCI, Net of Tax) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	$ 2,338	$ 2,102	$ 2,137	$ 1,825
Other comprehensive (loss) income before reclassifications			10
Amounts reclassified from AOCI			(5)
Total other comprehensive income	2	19	5	49
Ending Balance	2,357	2,139	2,357	2,139
Foreign Currency Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance			(20)
Other comprehensive (loss) income before reclassifications			(20)
Amounts reclassified from AOCI			0
Total other comprehensive income			(20)
Ending Balance	(40)		(40)
Derivative Instruments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance			(36)
Other comprehensive (loss) income before reclassifications			31
Amounts reclassified from AOCI			6
Total other comprehensive income			37
Ending Balance	1		1
Actuarial Gain (Loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance			51
Other comprehensive (loss) income before reclassifications			(1)
Amounts reclassified from AOCI			(14)
Total other comprehensive income			(15)
Ending Balance	36		36
Prior Service (Cost) Credit
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance			(20)
Other comprehensive (loss) income before reclassifications			0
Amounts reclassified from AOCI			3
Total other comprehensive income			3
Ending Balance	(17)		(17)
AOCI Attributable to Parent
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(22)	(4)	(25)	(34)
Total other comprehensive income	2	19	5	49
Ending Balance	$ (20)	$ 15	$ (20)	$ 15

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Reclassification from AOCI) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of revenue	$ 7,709	$ 6,647	$ 22,545	$ 20,104
Interest expense	39	34	105	97
Other expense (income)	1	(4)	(2)	(7)
Total amounts reclassified from AOCI	(218)	(169)	(681)	(521)
Loss to be reclassified in next 12 months			20
Reclassification out of AOCI
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Total amounts reclassified from AOCI	6	(4)	(5)	(41)
Reclassification out of AOCI | Realized losses (gain) on derivative instruments | Foreign exchange contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of revenue	9	(4)	4	(43)
Reclassification out of AOCI | Realized losses (gain) on derivative instruments | Interest rate contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Interest expense	0	0	2	2
Reclassification out of AOCI | Actuarial gain
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Other expense (income)	(4)	0	(14)	0
Reclassification out of AOCI | Prior service cost
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Other expense (income)	$ 1	$ 0	$ 3	$ 0

Stockholders' Equity (Recognize

Stockholders' Equity (Recognized Stock-Based Compensation) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 16	$ 19	$ 67	$ 76
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	13	16	57	68
Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 3	$ 3	$ 10	$ 8

Stockholders' Equity (Additiona

Stockholders' Equity (Additional Information) (Details) - shares	9 Months Ended
	May 31, 2022	May 31, 2021
Time-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Restricted stock units awarded (in shares)	700,000	1,200,000
Performance-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Restricted stock units awarded (in shares)	200,000	400,000
Performance-based restricted stock units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	150%
Market-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Restricted stock units awarded (in shares)	200,000	300,000
Market-based restricted stock units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	200%
2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available to be issued	9,940,536

Stockholders' Equity (Stock-bas

Stockholders' Equity (Stock-based Compensation Information) (Details) $ in Millions	9 Months Ended
	May 31, 2022 USD ($)
Share-based Payment Arrangement [Abstract]
Unrecognized stock-based compensation expense—restricted stock units	$ 44
Remaining weighted-average period for restricted stock units expense	1 year 6 months

Stockholders' Equity (Common St

Stockholders' Equity (Common Stock Outstanding) (Details) - USD ($)	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021	Jul. 31, 2021
Common stock outstanding:
Common stock outstanding, beginning balances (in shares)			144,496,077
Common stock outstanding, ending balance (in shares)	138,851,189		138,851,189
2022 Share Repurchase Program
Common stock outstanding:
Share repurchase program, amount authorized					$ 1,000,000,000
Number of shares repurchased (in shares)			8,600,000
Value of shares repurchased			$ 517,000,000
Share repurchase program, remaining amount available	$ 483,000,000		$ 483,000,000
Common stock:
Common stock outstanding:
Common stock outstanding, beginning balances (in shares)	142,392,135	149,366,501	144,496,077	150,330,358
Shares issued upon exercise of stock options (in shares)	0	9,321	0	9,321
Shares issued under employee stock purchase plan (in shares)	1,686	0	522,169	771,548
Vesting of restricted stock (in shares)	13,609	12,787	2,467,324	2,253,923
Purchases of treasury stock under employee stock plans (in shares)	(3,766)	(3,436)	(704,040)	(613,715)
Treasury shares purchased (in shares)	(3,552,475)	(2,547,707)	(7,930,341)	(5,913,969)
Common stock outstanding, ending balance (in shares)	138,851,189	146,837,466	138,851,189	146,837,466

Concentration of Risk and Seg_3

Concentration of Risk and Segment Data (Additional Information) (Details)	9 Months Ended
	May 31, 2022 country
Revenue, Major Customer [Line Items]
Number of operating countries (more than)	30
Five Largest Customers | Net revenue | Customer concentration
Revenue, Major Customer [Line Items]
Concentration risk	45%
Seventy Nine Customers | Net revenue | Customer concentration
Revenue, Major Customer [Line Items]
Concentration risk	90%

Concentration of Risk and Seg_4

Concentration of Risk and Segment Data (Segment Income) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income	$ 278	$ 213	$ 879	$ 707
Reconciling items:
Amortization of intangibles	(8)	(12)	(24)	(35)
Stock-based compensation expense and related charges	(16)	(19)	(67)	(76)
Restructuring, severance and related charges	0	(1)	0	(6)
Loss on debt extinguishment	(4)	0	(4)	0
Gain on securities	0	2	0	2
Interest income	1	1	2	5
Interest expense	(39)	(34)	(105)	(97)
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income	352	277	1,096	927
Operating Segments | EMS
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income	208	137	507	357
Operating Segments | DMS
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income	144	140	589	570
Segment Reconciling Items
Reconciling items:
Amortization of intangibles	(8)	(12)	(24)	(35)
Stock-based compensation expense and related charges	(16)	(19)	(67)	(76)
Restructuring, severance and related charges	0	(1)	0	(6)
Business interruption and impairment charges, net	0	0	0	1
Acquisition and integration charges	0	0	0	(4)
Gain on securities	0	2	0	2
Other expense (net of periodic benefit cost)	(8)	(1)	(19)	(10)
Interest income	1	1	2	5
Interest expense	$ (39)	$ (34)	$ (105)	$ (97)

Concentration of Risk and Seg_5

Concentration of Risk and Segment Data (Revenues Disaggregated by Segment) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Disaggregation of Revenue [Line Items]
Net revenue	$ 8,328	$ 7,215	$ 24,448	$ 21,876
Point in time
Disaggregation of Revenue [Line Items]
Net revenue	3,150	2,787	9,672	8,685
Over time
Disaggregation of Revenue [Line Items]
Net revenue	5,178	4,428	14,776	13,191
EMS
Disaggregation of Revenue [Line Items]
Net revenue	4,491	3,643	12,123	10,415
EMS | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	1,755	1,346	4,489	3,222
EMS | Over time
Disaggregation of Revenue [Line Items]
Net revenue	2,736	2,297	7,634	7,193
DMS
Disaggregation of Revenue [Line Items]
Net revenue	3,837	3,572	12,325	11,461
DMS | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	1,395	1,441	5,183	5,463
DMS | Over time
Disaggregation of Revenue [Line Items]
Net revenue	$ 2,442	$ 2,131	$ 7,142	$ 5,998

Concentration of Risk and Seg_6

Concentration of Risk and Segment Data (Foreign Source Revenue) (Details)	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Foreign source revenue | Net revenue | Foreign source revenue
Concentration Risk [Line Items]
Concentration risk	82.60%	82.70%	83.70%	83.60%

Income Taxes - Schedule of U.S.

Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate Compared to Actual Income Tax Expense (Details)	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Income Tax Disclosure [Abstract]
U.S. federal statutory income tax rate	21%	21%	21%	21%
Effective income tax rate	21.80%	20.30%	22.50%	26%

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) $ in Millions	3 Months Ended
	May 31, 2022 USD ($)
Income Tax Disclosure [Abstract]
Income tax expense for unrecognized tax benefit	$ 17

Earnings Per Share and Divide_3

Earnings Per Share and Dividends (Earnings Per Share) (Details) - shares	3 Months Ended		9 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common shares excluded from computation of diluted earnings per share (in shares)	430,900	665,000	431,700	665,000

Earnings Per Share and Divide_4

Earnings Per Share and Dividends (Dividends) (Details) - USD ($) $ / shares in Units, $ in Millions	Apr. 21, 2022	Jan. 20, 2022	Oct. 21, 2021	Apr. 22, 2021	Jan. 21, 2021	Oct. 15, 2020
Earnings Per Share [Abstract]
Dividend per Share	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08
Total of Cash Dividends Declared	$ 12	$ 12	$ 12	$ 12	$ 12	$ 12

Fair Value Measurements (Fair V

Fair Value Measurements (Fair Value Measurements on a Recurring Basis) (Details) - Recurring - USD ($) $ in Millions	May 31, 2022	Aug. 31, 2021
Level 1 | Cash equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	$ 10	$ 36
Level 1 | Prepaid expenses and other current assets
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments	17	18
Level 2 | Prepaid expenses and other current assets | Designated as hedging instruments | Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative asset	8	9
Level 2 | Prepaid expenses and other current assets | Not Designated as Hedging Instruments | Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative asset	18	20
Level 2 | Other assets | Designated as hedging instruments | Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative asset	9	9
Level 2 | Accrued expenses | Designated as hedging instruments | Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	25	6
Level 2 | Accrued expenses | Not Designated as Hedging Instruments | Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	56	9
Level 2 | Accrued expenses | Not Designated as Hedging Instruments | Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	0	3
Extended interest rate swap not designated as a hedging instrument	0	10
Level 2 | Other liabilities | Designated as hedging instruments | Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	$ 0	$ 7

Fair Value Measurements (Assets

Fair Value Measurements (Assets Held For Sale Measured At Fair Value) (Details) - Carrying Amount - USD ($) $ in Millions	9 Months Ended
	May 31, 2022	Aug. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets held for sale	$ 0	$ 61
Property, Plant and Equipment, Disposals	$ 61

Fair Value Measurements (Fair_2

Fair Value Measurements (Fair Value of Financial Instruments) (Details) - USD ($) $ in Millions	May 31, 2022	May 04, 2022	Aug. 31, 2021	Jul. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	$ 2,875		$ 2,878
Senior Notes | 4.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate (as a percent)	4.70%
Carrying Amount	$ 0		499
Senior Notes | 4.900% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate (as a percent)	4.90%
Carrying Amount	$ 300		300
Senior Notes | 3.950% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate (as a percent)	3.95%
Carrying Amount	$ 497		496
Senior Notes | 3.600% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate (as a percent)	3.60%
Carrying Amount	$ 496		495
Senior Notes | 3.000% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate (as a percent)	3%			3%
Carrying Amount	$ 592		591
Senior Notes | 1.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate (as a percent)	1.70%
Carrying Amount	$ 496		496
Senior Notes | 4.250% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate (as a percent)	4.25%	4.25%
Carrying Amount	$ 493		0
Senior Notes | Carrying Amount | Level 2 | 4.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	0		499
Senior Notes | Carrying Amount | Level 2 | 3.950% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	497		496
Senior Notes | Carrying Amount | Level 2 | 3.600% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	496		495
Senior Notes | Carrying Amount | Level 2 | 3.000% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	592		591
Senior Notes | Carrying Amount | Level 2 | 1.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	496		496
Senior Notes | Carrying Amount | Level 2 | 4.250% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	493		0
Senior Notes | Carrying Amount | Level 3 | 4.900% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	300		300
Senior Notes | Fair Value | Level 2 | 4.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	0		521
Senior Notes | Fair Value | Level 2 | 3.950% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	492		555
Senior Notes | Fair Value | Level 2 | 3.600% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	459		541
Senior Notes | Fair Value | Level 2 | 3.000% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	522		618
Senior Notes | Fair Value | Level 2 | 1.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	455		504
Senior Notes | Fair Value | Level 2 | 4.250% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	497		0
Senior Notes | Fair Value | Level 3 | 4.900% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 305		$ 322